Abstract
Alcohol-associated liver disease (ALD) is the most common indication for patients undergoing liver transplantation (LT) in the United States. There is an increased interest in performing LT for alcohol-associated hepatitis (AH) in select patients who fail to respond to medical therapy. The American Association for the Study of Liver Diseases endorses the use of alcohol biomarkers to aid in the diagnosis and management of ALD.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
